In 2019, the Global Market for Fertility Enhancing Treatments reached a size of USD 4.62 billion, and it is projected to attain USD 6.96 billion by 2027, demonstrating a Compound Annual Growth Rate (CAGR) of approximately 5.5% during the forecast period.
The expansion of the fertility enhancement treatment market is primarily propelled by factors such as the global decline in fertility rates, an increase in the number of clinics addressing this issue worldwide, technological advancements, and growing public-private investments in the market.
Get a sample copy of the Fertility Enhancing Treatment Market report: https://www.reportsanddata.com/download-free-sample/3515
Infertility, characterized by the inability to achieve pregnancy, is on the rise. Fertility rates, which measure the average number of children per woman, are steadily decreasing globally due to various factors such as delayed marriages, conception at a later age, and rising age-related infertility. Projections indicate a decline in global fertility rates from 2.4 children per woman in 2030 to 2.2 children per woman in 2050. This downward trend has led to a substantial surge in the demand for fertility enhancement devices catering to both males and females to extend the conception window.
Apart from surgeries, numerous Assisted Reproductive Technology (ART) procedures, including in vitro fertilization (IVF), are performed annually worldwide. The cost of IVF treatment varies across countries due to a lack of reimbursement policies. The average cost of a single IVF cycle is USD 12,000, excluding medication expenses; if a couple undergoes three cycles, the total out-of-pocket cost amounts to USD 33,000. In developing countries like India, the average cost of one IVF cycle is nearly USD 1,086, inclusive of medications. Therefore, the high cost of assisted reproductive techniques, coupled with a lack of insurance coverage in developed countries, hinders the market's growth.
The fertility enhancement treatment market is segmented based on treatment type, gender, distribution channel, and geography. Treatment types include drugs for women and men. Gender-wise segmentation distinguishes between male and female populations. Distribution channels encompass hospital pharmacy, retail pharmacy, drug stores, and e-commerce.
Regionally, the global fertility enhancement treatment market is divided into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America takes the lead, driven by lifestyle changes, product innovations, and early treatment adoption. Europe stands as the second-largest market due to development activities and a robust research base. The Asia Pacific market is poised for significant growth due to sedentary lifestyles, rapid population expansion, a large target patient pool, the adoption of Western lifestyles, and increased research and development.
Key players in the fertility enhancement treatment market include Monash IVF, CooperSurgical Inc., Vitrolife AB, Merck & Co. Inc., Ferring Pharmaceuticals, Halotech DNA, IntegraMed America, Inc., and others.
The report further breaks down segments by treatment, gender, distribution channel, and region, providing detailed revenue insights for the years 2017-2027.
Explore Trending Reports:
Industrial Coatings Market-https://www.reportsanddata.com/report-detail/industrial-coatings-market
Trivalent Chromium Finishing Market-https://www.reportsanddata.com/report-detail/trivalent-chromium-finishing-market
Cosmetic Chemicals Market-https://www.reportsanddata.com/report-detail/cosmetic-chemicals-market
Coating Additives Market-https://www.reportsanddata.com/report-detail/coating-additives-market
Pigment Dispersion Market-https://www.reportsanddata.com/report-detail/pigment-dispersion-market
Request a customization of the report: https://www.reportsanddata.com/request-customization-form/3515
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
